APLT

Applied Therapeutics to Present on Diabetic Cardiomyopathy and Prevalence of Disease at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association

Applied Therapeutics Stock Moves Higher On FDA Fast Track Review For AT-007 In Rare Metabolic Disorder

Applied Therapeutics Granted Fast Track Designation by FDA for AT-007 for Galactosemia

Applied Therapeutics to Present at the UBS Global Healthcare Virtual Conference

Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences

Applied Therapeutics, Inc. Announces Closing of Public Offering

Applied Therapeutics Raises $69M Via Equity